- Posts:
- 0 (0 per day)
- Age:
- N/A
- Date Registered:
- May 03, 2024, 11:07:33 AM
- Local Time:
- May 21, 2024, 04:47:00 PM
- Last Active:
- May 03, 2024, 04:16:51 PM
Signature:
First studies assessing your efficacy associated with [177Lu]Lu-PSMA radioligand treatments (PSMA-RLT) demonstrated advantageous ends in prostate type